Patient Registry Software Market Size To Reach $2.3 Billion By 2027, On Account Of Increasing Incidence Of Chronic Diseases | Grand View Research, Inc.

Grand View Research, Inc. – Market Research And Consulting.
According to the report published by Grand View Research, Inc., growing adoption of electronic health registry (EHR) and increasing instances of chronic diseases such as cancer, diabetes, and cardiovascular diseases are expected to fuel the demands in the market.

The global patient registry software market size is expected to reach USD 2.3 billion by 2027, expanding at a CAGR of 11.7%. Rising demand for increasing the efficiency of healthcare processes and reducing its cost via higher technological penetration and exploring untapped potential are some of the key drivers of the market.  

Increasing number of clinical trials by major pharmaceutical and biotechnological companies is expected to drive the patient registry software market over the forecast period. The data obtained via patient registry software helps in tracking patients for clinical trials. Moreover, associated advantages such as increased cost-effectiveness, efficient resource management, and reduced healthcare IT cost, are further widening the scope for market growth. The industry players are also constantly trying to develop advanced registries which can be easily integrated with national registries for a better outcome.

For instance, in September 2019, Elekta signed a distribution agreement with DocSoft for the key patient-specific QA solution software namely EPIgray, MU2Net, and EPIbeam. These softwares will help to analyze the treatment plan for any diagnosed condition, for future purposes. This agreement is expected to increase the company’s market penetration in the coming years.

U.S. patient registry software market size, by functionality, 2016 - 2027 (USD Million)

Further key findings from the report suggest:

·      On the basis of product, Disease registry held the largest revenue share in the patient registry software market owing to the increasing demand to curb the disease burden and stringent regulations by the government bodies

·          On the basis of software, the standalone segment held the largest share in 2019 and is expected to witness a CAGR of over 11.0% by 2027. The growth can be attributed to advanced features offered by the software such as easy data retrieval and auto upgradation

·          On the basis of deployment model, the on-premise segment held the largest revenue share in 2019. This is due to enhanced data security options and ease of access

·          By database type, although commercial segment dominated the market, public database type segment is expected to show the fastest growth over the forecast period owing to its increased usage for research purposes

·          On the basis of functionality, the population health management segment held the largest revenue share in 2019. This is due to its growing adoption in developed countries for better patient care

·          By end-use, the pharma and medical device companies’ segment is expected to show the fastest growth over the forecast period, owing to the increasing use of registries by these companies for clinical trial enrollment

·          By region, Asia Pacific is expected to emerge as the fastest-growing region in this space. Moreover, North America held the largest revenue share due to its established healthcare structure and stringent regulations by the government bodies

“Would you Like/Try a Sample Report” Click the link below:

Grand View Research has segmented the global patient registry software market based on product, software, database type, deployment model, functionality, end-use, and region:

Patient Registry Software Product Outlook (Revenue, USD Million, 2016 – 2027)

  • Disease Registry

    • Cardiovascular

    • Diabetes

    • Cancer

    • Rare disease

    • Asthma

    • Others

  • Health Service Registry

  • Product Registry

    • Medical Device

    • Drug

Patient Registry Software Outlook (Revenue, USD Million, 2016 – 2027)

  • Standalone

  • Integrated

Patient Registry Software Deployment Model Outlook (Revenue, USD Million, 2016 – 2027)

  • On Premise

  • Web/Cloud based

Patient Registry Software Database Type Outlook (Revenue, USD Million, 2016 – 2027)

  • Commercial

  • Public

Patient Registry Software Functionality Outlook (Revenue, USD Million, 2016 – 2027)

  • Population Health Management

  • Health Information Exchange

  • Patient Care Management

  • Point-Of-Care

  • Medical Research & Clinical Studies

  • Product Outcome Evaluation

Patient Registry Software End-use Outlook (Revenue, USD Million, 2016 – 2027)

  • Government & Third Party

  • Hospitals & Medical Practices

  • Private Payers

  • Pharma & Medical Device Companies

  • Research Organization

Patient Registry Software Regional Outlook (Revenue, USD Million, 2016 – 2027)

  • North America

    • U.S.

    • Canada

  • Europe

    • U.K.

    • Germany

    • France

    • Italy

    • Spain

    • Sweden

  • Asia Pacific

    • Japan

    • China

    • India

    • Australia

    • Singapore

    • South Korea

  • Latin America

    • Brazil

    • Mexico

    • Argentina

  • Middle East & Africa

    • South Africa

    • Saudi Arabia

List of Key Players of Patient Registry Software Market

• Phytel, Inc.

• McKesson Corporation

• Quintiles

• Dacima Software Inc.

• ImageTrend, Inc.



Have Any Query? Ask Our Experts for More Details on Report:

Browse Related Reports @

Electronic Health Records Market –

Explore the BI enabled intuitive market research database, Navigate with Grand View Compass, by Grand View Research, Inc.

About Grand View Research

Grand View Research is a market research and consulting company based in the State of California with headquarters in San Francisco. The company offers consulting services tailored for business organizations to assist them with understanding and exploring their potential on a large scale. At the same time, Grand View Research caters to the individual research needs to provide a customized research service. 

Grand View Research is fully committed to offering the best research services in the Industry. Our dedicated team of experienced analysts offers the full capability and potential to precisely understand your research needs.

Media Contact
Company Name: Grand View Research, Inc.
Contact Person: Sherry James, Corporate Sales Specialist – U.S.A.
Email: Send Email
Phone: 1-415-349-0058, Toll Free: 1-888-202-9519
Address:201, Spear Street, 1100
City: San Francisco
State: California
Country: United States